Sun selling Ohio plant in post-Ranbaxy network restructure
Sun Pharma has announced it will divest a plant in Ohio to further consolidate manufacturing operations following its $4bn acquisition of Ranbaxy.
Sun Pharma has announced it will divest a plant in Ohio to further consolidate manufacturing operations following its $4bn acquisition of Ranbaxy.
AstraZeneca has invested £75m ($114m) to build packaging and warehouse facilities at its manufacturing site in Macclesfield, UK.
Protea Biosciences has teamed up with Agilent Technologies to offer drugmakers mass spectrometry alternatives to UV detection in QA/QC of recombinant proteins.